Long-term temporal evaluation of ground reaction forces during development of experimentally induced osteoarthritis in dogs

被引:78
作者
Budsberg, SC [1 ]
机构
[1] Univ Georgia, Coll Vet Med, Dept Small Anim Med, Athens, GA 30602 USA
关键词
D O I
10.2460/ajvr.2001.62.1207
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective-To describe changes in vertical ground reaction forces (GRF) over 48 months in dogs with osteoarthritis (OA) of the stifle joint induced by transection of a cranial cruciate ligament (CCL). Animals-12 clinically normal adult dogs. Procedure-Vertical GRF (eg, peak force and impulse) were determined prior to and 1, 2, 3, 6, 10, and 12 months after transection of the right CCL. In 7 dogs, data were also collected 24, 32, 38, 42, and 48 months after transection. Results-Vertical peak force and impulse were significantly decreased in the right hind limb at all times after transection, compared with baseline values. From 10 through 48 months after transection, vertical GRF remained essentially static. Ground reaction forces in the unoperated (left) hind limb also changed significantly during the study. Left vertical impulse significantly increased 3 months after transection, whereas at 24, 38, 42, and 48 months after transection, left vertical peak force was significantly decreased, compared with the baseline value. Mean intradog coefficients of variation (CV) for peak vertical force and impulse ranged from 7.38 and 9.32, respectively, 1 month after transection to 1.96 and 2.76, respectively, at 42 months. Conclusions and Clinical Relevance-Vertical GRF in the affected hind limb equilibrated approximately 10 months after CCL transection. Prior to this, force transmission across the affected stifle joint changed significantly over time. Intradog CV were small, indicating that GRF may be an appropriate outcome measurement for evaluation of OA development induced by CCL transection in dogs.
引用
收藏
页码:1207 / 1211
页数:5
相关论文
共 47 条
[1]  
ABATANGELO G, 1989, CLIN ORTHOP RELAT R, P278
[2]   THERAPEUTIC TREATMENT OF CANINE OSTEO-ARTHRITIS WITH GLYCOSAMINOGLYCAN POLYSULFURIC ACID ESTER [J].
ALTMAN, RD ;
DEAN, DD ;
MUNIZ, OE ;
HOWELL, DS .
ARTHRITIS AND RHEUMATISM, 1989, 32 (10) :1300-1307
[3]   PROPHYLACTIC TREATMENT OF CANINE OSTEO-ARTHRITIS WITH GLYCOSAMINOGLYCAN POLYSULFURIC ACID ESTER [J].
ALTMAN, RD ;
DEAN, DD ;
MUNIZ, OE ;
HOWELL, DS .
ARTHRITIS AND RHEUMATISM, 1989, 32 (06) :759-766
[4]   Clinical trials design: structure modifying agents for osteoarthritis. Future guidelines: areas for development [J].
Bellamy, N .
OSTEOARTHRITIS AND CARTILAGE, 1999, 7 (04) :424-426
[5]  
Bertram JEA, 1997, VET COMP ORTHOPAED, V10, P160
[6]  
BRANDT KD, 1991, J RHEUMATOL, V18, P436
[7]  
BRANDT KD, 1991, ARTHRITIS RHEUM-US, V34, P1560
[8]   Effects of diacerhein in an accelerated canine model of osteoarthritis [J].
Brandt, KD ;
Smith, G ;
Kang, SY ;
Myers, S ;
OConnor, B ;
Albrecht, M .
OSTEOARTHRITIS AND CARTILAGE, 1997, 5 (06) :438-449
[9]  
Budsberg SC, 1999, J AM VET MED ASSOC, V214, P206
[10]  
BUDSBERG SC, 1988, AM J VET RES, V49, P1522